Skip to content

Study on clinical safety evaluation of Guipi Mixture after marketing

Study on clinical safety evaluation of Guipi Mixture after marketing

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025001007
Enrollment
Unknown
Registered
2025-05-19
Start date
2025-01-15
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients using Guipi Mixture in monitored medical institutions in China

Interventions

Observation group:Patients who meet the instructions and indications of Guipi Mixture or according to the patients condition the clinician judges that it is suitable to apply Guipi Mixture and the doc

Sponsors

The First Affiliated Hospital of Gannan Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1: Patients who meet the instructions and indications of Guipi Mixture or are judged by the clinician to be suitable for the application of Guipi Mixture based on the patient's condition and the doctor has prescribed Guipi Mixture for them; 2: Patients who volunteered and signed the informed consent form 3: Willing to cooperate to complete at least one follow-up visit. Continuous medication for more than 14 days (420ml) is a case

Exclusion criteria

Exclusion criteria: 1: Patients who according to the investigator's judgment cannot complete or are not suitable for participation in this study

Design outcomes

Primary

MeasureTime frame
Adverse Events;

Countries

china

Contacts

Public ContactLin Tangtang

The First Affiliated Hospital of Gannan Medical University

lintangt@163.com15907976013

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026